Ammonium hydrogen tartrate
Common Name: |
Ammonium hydrogen tartrate |
IUPAC Name: |
azanium;2,3,4-trihydroxy-4-oxobutanoate |
Molecular Formula: |
C4H9NO6 |
SMILES: |
C(C(C(=O)[O-])O)(C(=O)O)O.[NH4+] |
Inchi: |
1S/C4H6O6.H3N/c5-1(3(7)8)2(6)4(9)10;/h1-2,5-6H,(H,7,8)(H,9,10);1H3 |
Inchi Key: |
ZMFVLYPTTFPBNG-UHFFFAOYSA-N |
Cas No: |
3095-65-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
3 |
Name |
Value |
Molecular Weight (g/mol) |
167.12 |
Mass (g/mol) |
167.043 |
Molar Refractivity |
31.25 |
Net Charge |
|
HBD |
4 |
HBA |
6 |
Rt Bonds |
3 |
Rings |
|
TPSA |
117.89 |
Hetero Atoms |
|
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
|
iLOGP |
0.00 |
XLOGP3 |
-4.89 |
WLOGP |
-3.08 |
MLOGP |
-6.67 |
ESOL Log S |
2.40 |
ESOL Solubility (mg/ml) |
42200 |
ESOL Solubility (mol/l) |
253 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
3.05 |
Ali Solubility (mg/ml) |
186000 |
Ali Solubility (mol/l) |
1120 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
2.44 |
Silicos-IT Solubility (mg/ml) |
46500 |
Silicos-IT Solubility (mol/l) |
278 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-10.79 |
Bioavailability Score |
0.56 |
Caco2 |
0 |
Human Intestinal Absorption |
0 |
Plasm Protein Binding |
0.454 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.863 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |